601 related articles for article (PubMed ID: 32283655)
41. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
Rao P; Knaus EE
J Pharm Pharm Sci; 2008 Sep; 11(2):81s-110s. PubMed ID: 19203472
[TBL] [Abstract][Full Text] [Related]
42. Potential role of selective COX-2 inhibitors in cancer management.
Dang CT; Shapiro CL; Hudis CA
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):30-6. PubMed ID: 12102578
[TBL] [Abstract][Full Text] [Related]
43. Inflammation: Biochemistry, cellular targets, anti-inflammatory agents and challenges with special emphasis on cyclooxygenase-2.
Kaur B; Singh P
Bioorg Chem; 2022 Apr; 121():105663. PubMed ID: 35180488
[TBL] [Abstract][Full Text] [Related]
44. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
45. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
Thun MJ; Henley SJ; Patrono C
J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387
[TBL] [Abstract][Full Text] [Related]
46. Spicy approach to cancer treatment.
Nath S
J Natl Cancer Inst; 2011 Dec; 103(24):1817-8. PubMed ID: 22157964
[No Abstract] [Full Text] [Related]
47. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.
Fiorucci S; Distrutti E
Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233
[TBL] [Abstract][Full Text] [Related]
48. NSAIDs and cancer prevention: targets downstream of COX-2.
Cha YI; DuBois RN
Annu Rev Med; 2007; 58():239-52. PubMed ID: 17100552
[TBL] [Abstract][Full Text] [Related]
49. Inflammation, Antiinflammatory Agents, and Alzheimer's Disease: The Last 22 Years.
McGeer PL; Rogers J; McGeer EG
J Alzheimers Dis; 2016 Oct; 54(3):853-857. PubMed ID: 27716676
[TBL] [Abstract][Full Text] [Related]
50. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
51. Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer.
De Monte C; Carradori S; Gentili A; Mollica A; Trisciuoglio D; Supuran CT
Curr Med Chem; 2015; 22(24):2812-8. PubMed ID: 26180003
[TBL] [Abstract][Full Text] [Related]
52. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
[TBL] [Abstract][Full Text] [Related]
53. Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update.
Cui J; Jia J
Curr Med Chem; 2021; 28(18):3622-3646. PubMed ID: 32942970
[TBL] [Abstract][Full Text] [Related]
54. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers.
Khanapure SP; Garvey DS; Janero DR; Letts LG
Curr Top Med Chem; 2007; 7(3):311-40. PubMed ID: 17305573
[TBL] [Abstract][Full Text] [Related]
55. Role of cyclooxygenase-2 in the development and treatment of oesophageal adenocarcinoma.
Buskens CJ; Ristimäki A; Offerhaus GJ; Richel DJ; van Lanschot JJ
Scand J Gastroenterol Suppl; 2003; (239):87-93. PubMed ID: 14743889
[TBL] [Abstract][Full Text] [Related]
56. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
Pasinetti GM
J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
[TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory phytochemicals for chemoprevention of colon cancer.
Madka V; Rao CV
Curr Cancer Drug Targets; 2013 Jun; 13(5):542-57. PubMed ID: 23597198
[TBL] [Abstract][Full Text] [Related]
58. Repurposing some of the Well-known Non-steroid Anti-inflammatory Drugs (NSAIDs) for Cancer Treatment.
Sousa SM; Xavier CPR; Vasconcelos MH; Palmeira A
Curr Top Med Chem; 2023; 23(13):1171-1195. PubMed ID: 36717997
[TBL] [Abstract][Full Text] [Related]
59. Sex differences in effects and use of anti-inflammatory drugs.
Demyanets S; Wojta J
Handb Exp Pharmacol; 2012; (214):443-72. PubMed ID: 23027462
[TBL] [Abstract][Full Text] [Related]
60. Polyamines and cancer: old molecules, new understanding.
Gerner EW; Meyskens FL
Nat Rev Cancer; 2004 Oct; 4(10):781-92. PubMed ID: 15510159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
